Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2010
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN101720323A Compounds with anti-cancer activity
06/02/2010CN101717374A Compound comprising fork biphenyl center and preparation method thereof
06/02/2010CN101205209B Method for refining atorvastatin intermediate
06/01/2010US7728148 Acyclic oximyl hepatitis C protease inhibitors
06/01/2010US7728032 biphenyl heterocycle derivatives; atherosclerosis, thrombosis, stroke, acute coronary syndrome, stable angina, peripheral vascular disease, ischemia, intermittent claudication, abdominal aortic aneurysm, myocardial infarction; 2-(4-Benzyloxy-phenoxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester
06/01/2010US7728019 Biphenylcarboxamides
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism
05/2010
05/27/2010WO2010059922A1 Pyrrolidine carboxamide compounds
05/27/2010WO2010059639A2 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010059390A1 Modulators of serotonin receptor
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058429A1 A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines
05/27/2010WO2010058402A1 Novel anti-biofilm agents
05/27/2010WO2010058019A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010058018A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010057917A1 Process for preparing an n-alkyllactam with improved color quality
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009129387A3 Cationic lipids and uses thereof
05/27/2010US20100130749 Methods
05/27/2010US20100130743 Heterocycle-substituted, n-phenyl-phthalamide derivatives, related compounds and their use as insecticides
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130584 Novel compounds from antrodia camphorata
05/27/2010US20100130583 Prolinamide derivatives as modulators of voltage-gated sodium channels
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010CA2744308A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010CN1974545B Long chain fatty acyl amide compound and its application
05/26/2010CN1953963B Process for producing cyclic N-hydroxyimide compound
05/26/2010CN1922482B Detection cartridges and methods
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1720245B Oxime ester photoinitiators with heteroaromatic groups
05/26/2010CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101712632A Substituted tetracycline compounds
05/25/2010USRE41356 Hepatitis C inhibitor tri-peptides
05/25/2010US7723530 Used in electrooptical systems such as TV screens, liquid crystal displays, charge coupled devices, plasma displays or electroluminescent displays; do not tend to aggregate, show very good dispersibility; high transparence and pure hue
05/25/2010US7723529 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-[(3-(nitrooxy) propyl)carbonyloxy]methyl-1H-imidazole
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723332 Aryl sulfonamides useful for modulation of the progesterone receptor
05/25/2010US7723327 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010US20100125076 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
05/20/2010US20100125075 Antibacterial Agents
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186800A1 New mandelic acid derivatives and their use as thrombin inhibitors
05/19/2010EP2185561A2 1,2,3,4-tetrahydropyrroloý1,2-a¨pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrroloý1,2-a¨ý1,4¨-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof
05/19/2010EP2185507A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
05/19/2010EP2185506A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
05/19/2010EP1558246B1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
05/19/2010CN101711234A New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
05/19/2010CN101709047A Chemical complete synthesis method for 22nd natural amino acid-pyrrolysine
05/19/2010CN101709046A Synthetic method of N-methyl-2-chloroethyl pyrrolidine
05/19/2010CN101239937B Method for preparing optical activity R-(-)-1-benzylcarbonyl-3-aminopyrrolidine and hydrochloride thereof
05/19/2010CN101066945B Process of synthesizing 3-substituted lactan compound
05/18/2010US7718794 Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718693 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration
05/18/2010US7718683 Triazolyl phenyl benzenesulfonamides
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718186 2-alkoxy-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives
05/18/2010CA2460935C An improved preparation of atorvastatin
05/14/2010WO2010053323A2 Cytoplasm exposure additive for exposing particles delivered into cells to cytoplasm from endocytic vesicles, and exposing method
05/14/2010WO2010053165A1 Vitamin d3 lactam derivative
05/14/2010WO2010052625A1 Pyrrolidines
05/14/2010WO2010051935A2 Substituted amido phenoxybenzamides
05/14/2010WO2010009405A3 Targeted nitroxide agents
05/14/2010CA2741589A1 Pyrrolidines
05/13/2010US20100121062 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
05/13/2010US20100121055 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
05/13/2010US20100120890 Ion channel modulating activity i
05/13/2010US20100120888 Atorvastatin strontium salt and pharmaceutical composition comprising same
05/13/2010US20100120845 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
05/13/2010US20100120793 Pyrrolidines
05/13/2010US20100120615 4-cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
05/12/2010EP2184283A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity
05/12/2010EP2183216A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
05/12/2010EP2182800A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
05/12/2010EP1931630B1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN201466101U Lithium ion battery coating procedure NMP reclaimer
05/12/2010CN1580043B Anti malignant tumour southern radix bupleuri extract preparing method
05/12/2010CN101704812A Azasugar compounds and preparation method and application thereof
05/12/2010CN101704778A Method for preparing 4-hydroxyl yrrolidone-2-acetamide
05/12/2010CN101703501A Propargyl imine compounds and use thereof in preparation of MAO inhibitor
05/12/2010CN101113146B Process for the separation of blood fat recovery purpose-made monascus active ingredient
05/11/2010US7714147 Method for preparing Fmoc-based hydrolysable linkers
05/11/2010US7714131 Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
05/11/2010US7714022 Decrease the secretion of the amyloid plaque forming peptide, A beta 42; neurodegenerative disease such as mild cognitive impairment, Alzheimer's disease and MCI (mild cognitive impairment); carboxy-substituted 1,2-diphenylpyrroles
05/11/2010US7714021 Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
05/11/2010US7714020 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
05/11/2010US7714012 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
05/11/2010US7713979 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2456095C An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 404